Partridge Ann H, Winer Eric P
Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Breast Dis. 2004;21:55-64. doi: 10.3233/bd-2004-21108.
The benefits of adjuvant chemotherapy for early stage breast cancer must be considered in light of the potential risks and anticipated side effects. When considering a course of adjuvant chemotherapy for a patient, one should not only consider acute side effects of treatment, but should understand the long-term risks of therapy. Sustained or long-term effects of adjuvant chemotherapy usually have either a late onset or a sustained impact--often lasting for many years. In the case of some of the rare long-term complications, many years may elapse before any symptoms develop. This review details sustained and long-term complications of adjuvant chemotherapy including information about risk factors, etiology, and incidence rates for specific complications. Interventions to ameliorate long-term complications are also addressed.
必须根据潜在风险和预期副作用来考虑辅助化疗对早期乳腺癌的益处。在为患者考虑辅助化疗疗程时,不仅应考虑治疗的急性副作用,还应了解治疗的长期风险。辅助化疗的持续或长期影响通常要么发病较晚,要么具有持续影响——往往会持续多年。对于某些罕见的长期并发症,可能要过很多年才会出现任何症状。本综述详细介绍了辅助化疗的持续和长期并发症,包括特定并发症的风险因素、病因和发病率信息。还讨论了改善长期并发症的干预措施。